NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Nov 2, 2026
Sale
Calculated transaction value
$38.91K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Nov 2, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$25.7
Nov 2, 2026
First close after public filing
$25.82
Nov 3, 2026
Return after filing · so far
-40.74%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,452 shares @ $26.8
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000023
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$145.6K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Nov 2, 2026 | $38.91K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Nov 2, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Nov 2, 2026 | $2.7K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Sale | Oct 30, 2026 | $103.99K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |